John Richards

Our People


John Richards

, -

Phone: (212) 708-1915 | Fax: (212) 246-8959

John Richards is Of Counsel and resident in the New York Office of Ladas & Parry and has more than four decades of patent experience.

John specializes in chemical and biochemical patent matters including drafting and prosecution of patent applications in these fields in the United States, Europe and abroad. John handled the global patenting and licensing for the groundbreaking Alzheimer’s Disease drug known as
Razadyne in the U.S and Reminyl internationally.

With respect to Europe, he handles matters for clients of the firm’s London, Munich and New York offices before both the UK Intellectual Property Office and the European Patent Office (EPO). He is also widely experienced in the negotiation and drafting of patent know-how and license agreements.

John started work in the patent profession in the patent department of the British chemical company Albright & Wilson in 1966. He joined Ladas & Parry in 1973, becoming a partner in 1982.

He is the general editor of Legal Aspects of Introducing Products to the United States (Kluwer 1988) and co-author of Intellectual Property and the Internal Market of the European Community (Graham & Trotman 1993).

John is an adjunct associate professor at Fordham University School of Law where he teaches U.S. and international patent law and at John Marshall Law School in Chicago where he teaches a course in international patent law. He has written and spoken frequently on international intellectual property issues, especially in the fields of patents and copyrights in the United States, Canada, India and the Far East. He has been identified as a New York Super Lawyer.

In his spare time, John enjoys teaching.


University of Cambridge (B.A., 1966; M.A., 1970)
University of London (LL.B., 1979)


New York
U.S. Patent and Trademark Office – Registered Patent Attorney
Licensed to practice before the European Patent Office (EPO)
Licensed to practice before the British Patent Office
Registered to Practice before the European Office of Harmonization of the Internal Market (EOHIM)(Trademarks and Designs)

Key Industries
  • Pharmaceuticals
  • Technology
Publications & Presentations

See Posts By John Richards

  • Intellectual Property Magazine March 2012 – IP Challenges in Three Dimensional Printing
  • Intellectual Property Magazine February 2012  – Stop Online Piracy Act Under Siege
  • Intellectual Property Magazine June 2011 – U.S. White Paper on IP Enforcement
  • New Matter, March 2010: Controlling Patent Costs using PCT
  • Handbook of European Intellectual Property Management,  Kogan Page, London 2009 Chapter on Controlling Patent Costs
  • Expert Opinion Therapeutics Patents (2008) 18 (10): 1191- 1194 Patent issues relating to hybrid drugs
  • World Jurist Association Vol 41, No 1 (May 2008) Patent Protection for Inventions Involving Newly Found Biochemical Mechanisms
  • International Considerations in IP Licensing, The Licensing Journal, February 2007
  • Bioforum Europe, October 2006 Patent Protection: Inventions Involving Newly Found Biochemical Mechanisms
  • Intellectual Property and the Internal Market of the European Community, Graham & Trotman 1993, Co-Authored
  • Legal Aspects of Introducing Products to the United States, Kluwer 1988, General Editor
  • Adjunct Associate Professor, Fordham University School of Law
  • Adjunct Associate Professor, John Marshall Law School